Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Clorox

Clorox Stock Strengthens; Ready To Return To Former Glory Days?

Clorox stock shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 82.

Investors Business Daily

Best air purifiers in 2024 tested and rated

We tested a range of models to find the best air purifiers to suit every budget and room size.

Tom’s Guide

Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022

Upgrades

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

These 4 Blue Chip Recession-Proof Stocks Can Hedge Your Portfolio As Global Recession Imminent

As the pain of a global recession is already being felt and markets have been volatile, investors are searching for companies that can withstand the macroeconomic headwinds.

Benzinga

Clorox (CLX) Readies For Q4 Earnings: What's In The Cards?

The Clorox Company CLX is likely to register top-line growth when it reports fourth-quarter fiscal 2022 earnings on Aug 3. The Zacks Consensus Estimate for quarterly revenues is pegged at $1,856 million, suggesting a rise of around 3% from the prior-year quarter's reported figure.

Benzinga

7 Analysts Have This to Say About Clorox

Over the past 3 months, 7 analysts have published their opinion on Clorox (NYSE:CLX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Clorox vs. Newell Brands: Which Consumer Defensive Stock is a Better Investment?

The stock market has been facing immense volatility lately due to multi-decade high inflation. However, amid high inflationary pressures, consumer defensive stocks tend to remain resilient because of these companies' inelastic demand for products. Consumer defensive stocks The Clorox Company (CLX) and Newell Brands (NWL) look well-positioned to survive the…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Where Clorox Stands With Analysts

Analysts have provided the following ratings for Clorox (NYSE:CLX) within the last quarter:

Benzinga

Looking Into Clorox's Recent Short Interest

Clorox's (NYSE:CLX) short percent of float has risen 19.39% since its last report. The company recently reported that it has 5.74 million shares sold short, which is 4.68% of all regular shares that are available for trading.

Benzinga

Clorox's Return on Invested Capital Insights

According to Benzinga Pro, during Q3, Clorox (NYSE:CLX) earned $152.00 million, a 111.11% increase from the preceding quarter. Clorox also posted a total of $1.81 billion in sales, a 6.98% increase since Q2.

Benzinga

What 10 Analyst Ratings Have To Say About Clorox

Analysts have provided the following ratings for Clorox (NYSE:CLX) within the last quarter:

Benzinga

Recap: Clorox Q3 Earnings

Clorox (NYSE:CLX) reported its Q3 earnings results on Monday, May 2, 2022 at 04:15 PM. Here's what investors need to know about the announcement. Earnings Clorox beat estimated earnings by 35.05%, reporting an EPS of $1.31 versus an estimate of $0.97.

Benzinga

Why Clorox Shares Are Sliding After Hours

Clorox Co (NYSE: CLX) shares are trading lower in Monday's after-hours session after the company reported financial results and cut its full-year earnings forecast.

Benzinga

Earnings Preview For Clorox

Clorox (NYSE:CLX) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Clorox will report an earnings per share (EPS) of $0.97.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Clorox: Dividend Insights

Monday marks the last chance for investors to receive the next dividend payout from Clorox (NYSE:CLX).

Benzinga

Expert Ratings For Clorox

Analysts have provided the following ratings for Clorox (NYSE:CLX) within the last quarter:

Benzinga

Where Clorox Stands With Analysts

Over the past 3 months, 9 analysts have published their opinion on Clorox (NYSE:CLX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

StockNews.com

Should You Buy Clorox Stock on the Dip?

The shares of Clorox (CLX) have tumbled more than 14% in price on the company’s worse-than-expected earnings release and diminished full-year guidance. The company is currently grappling with inflationary pressures and supply disruptions, which are negatively impacting its margins. So, with Clorox’s 44-year history of consecutive dividend growth, is the…

Get all your
news in one place.

100’s of premium titles.
One news app.

Axios

The era of hygiene theater is over

Clorox’s health and wellness sales fell 21% year-over-year in the quarter ending Dec. 31.

Benzinga

Analyst Ratings For Clorox

Clorox (NYSE:CLX) has observed the following analyst ratings within the last quarter:

Benzinga

Clorox Earnings Perspective: Return On Invested Capital

Pulled from Benzinga Pro data, Clorox (NYSE:CLX) posted Q2 earnings of $72.00 million, an increase from Q1 of 49.65%. Sales dropped to $1.69 billion, a 6.37% decrease between quarters.

Benzinga

Recap: Clorox Q2 Earnings

Clorox (NYSE:CLX) reported its Q2 earnings results on Thursday, February 3, 2022 at 04:15 PM. Here's what investors need to know about the announcement.

Benzinga

A Bullish Sign Appears On Clorox's Chart

If history is any guide, there may be good fortune ahead for shares of Clorox (NYSE:CLX). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Benzinga

Credit Suisse Downgrades This Cleaning Products Manufacturer - Read Why

Credit Suisse analyst Kaumil Gajrawala downgraded Clorox Co (NYSE:CLX) to Underperform from Neutral with a $160 price target. The analyst thinks a large portion of Clorox's growth during the first phase of the pandemic came from categories that are now declining. If consumption continues to revert toward pre-pandemic levels, $500 million in company sales may…

Benzinga

Clorox's Ex-Dividend Date Is Monday, Here's What You Need To Know

Monday marks the last chance for investors to receive the next dividend payout from Clorox.

1 2 3

Organisations

Regeneron Pharmaceuticals

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

United States

260,269 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.